Capital Bank & Trust’s Bio-Techne TECH Stock Holding History

Capital Bank & Trust’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-96	Closed	-$5K	–	832
2019 Q3	$5K	Buy	+96	New	+$4.81K	﹤0.01%	613

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Capital Bank & Trust's TECH Position: Q4 2019 in Review

Capital Bank & Trust sold out of Bio-Techne (TECH) in Q4 2019, closing a stake of 96 shares — an estimated $5K sold.

Capital Bank & Trust first reported a position in TECH in Q3 2019 and held it in 1 quarter. The position peaked at $5K in Q3 2019. 376 funds tracked by Wall St. Rank hold TECH as of Q4 2019.

Capital Bank & Trust reported no remaining Bio-Techne position as of Q4 2019 after selling out during the quarter.
Capital Bank & Trust sold 96 Bio-Techne shares in Q4 2019, an estimated $5K.
Capital Bank & Trust first reported a position in Bio-Techne in Q3 2019 and held it in 1 quarter.
Capital Bank & Trust's Bio-Techne position peaked at $5K in Q3 2019.
376 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2019.

Based on Capital Bank & Trust's 13F filing for Q4 2019, filed 18 Feb 2020.